|
Mar 14
|
MeiraGTx and Hologen launch AI-backed gene therapy venture
|
|
Mar 13
|
MeiraGTx spins Parkinson’s, obesity gene therapies into AI startup
|
|
Mar 13
|
MeiraGTx Reports Fourth Quarter and Full Year 2024 Financial and Operational Results and Recent Business Updates
|
|
Mar 13
|
MeiraGTx Enters into a Strategic Collaboration with Hologen AI to Expedite Phase 3 Development of AAV-GAD for Parkinson’s Disease and Industrialize MeiraGTx’s Proprietary Manufacturing Process
|
|
Feb 21
|
MeiraGTx Announces The Lancet Publication of Data Demonstrating the Efficacy of rAAV8.hRKp.AIPL1 for the Treatment of Leber Congenital Amaurosis 4 (LCA4) Retinal Dystrophy
|
|
Jan 2
|
High Growth Tech Stocks in the United States
|
|
Dec 29
|
MeiraGTx Holdings plc (MGTX): Is This Gene Therapy Stock a Good Buy Right Now?
|